This is the logo of the provider
EASD 2025 15 - 19 September 2025

Revolutionising Cardiometabolic Health: Innovating, Transforming and Progressing Care

Meeting description
Meeting recording (Part 3)
Meeting recording (Part 4)
Meeting recording (Part 5)
Download poster (.pdf)
Download poster (.pdf)
Download infographic (.pdf)
Download poster (.pdf)
Download poster (.pdf)
This is the logo of the provider
{{ getPageNum(PDFPage) }}
This is the logo of the provider
{{ getPageNum(PDFPage) }}
This is the logo of the provider
{{ getPageNum(PDFPage) }}
This is the logo of the provider
{{ getPageNum(PDFPage) }}
This is the logo of the provider
{{ getPageNum(PDFPage) }}
Meeting recording (Part 1)
Meeting recording (Part 2)
Monday, 15 September 2025
09:00 - 10:40
(CEST)

Part 1: Exploring the background of person-centred care across the spectrum of related cardiometabolic diseases

09:00 - 09:15
(CEST)

The Prologue: welcome and introductions

Alice Cheng, Mikael Rydén
09:15 - 09:35
(CEST)

Chapter 1: Person-centred care - the evolving landscape and new horizons in obesity management

Carel le Roux
09:35 - 09:55
(CEST)

Chapter 2: Person-centred care - the need for treatment of cardiometabolic diseases

John Buse
09:55 - 10:10
(CEST)

Chapter 3: Focus on PAD - synergistic strategies across ASCVD

Subodh Verma
10:10 - 10:25
(CEST)

Chapter 4: Person-centred care - heart failure for people with cardiometabolic diseases

Michele Senni
10:25 - 10:40
(CEST)

Chapter 5: Summarising the evidence for person-centred care across cardiometabolic diseases

Alice Cheng, Mikael Rydén, Carel le Roux, John Buse, Subodh Verma, Michele Senni
10:55 - 12:05
(CEST)

Part 2: Focusing in on an expanding spectrum of cardiometabolic diseases and patient phenotypes

10:55 - 11:00
(CEST)

Checking the contents page: welcome back

Alice Cheng, Mikael Rydén
11:00 - 11:15
(CEST)

Chapter 6: Focus on kidneys - synergistic strategies across cardiometabolic diseases

Christoph Wanner
11:15 - 11:35
(CEST)

Chapter 7: Focus on MASH - integrating emerging data into clinical pathways

Laurent Castera
11:35 - 11:50
(CEST)

Chapter 8: Focus on childhood - charting new paths in obesity management

Antje Körner
11:50 - 12:05
(CEST)

Chapter 9: Summarising the focus and translating it into clinical practice

Alice Cheng, Mikael Rydén, Christoph Wanner, Laurent Castera, Antje Körner
12:45 - 14:10
(CEST)

Part 3: Semaglutide and the path to holistic cardiometabolic disease care

12:45 - 12:50
(CEST)

Checking the contents page: welcome back

Alice Cheng, Mikael Rydén
12:50 - 13:15
(CEST)

Chapter 10: The prequel to semaglutide and the evidence that started the journey

Anna Secher
13:15 - 13:40
(CEST)

Chapter 11: The science of the cardiometabolic care - clinical evidence and perspectives

Arya M. Sharma
13:40 - 13:55
(CEST)

Chapter 12: The voice of the patient - hearing their call to action for personalised care

13:55 - 14:10
(CEST)

Chapter 13: Summarising the journey and exploring the
co-authors’ views

Alice Cheng, Mikael Rydén, Anna Secher, Arya M. Sharma
14:25 - 15:50
(CEST)

Part 4: The future chapters - advancing the management of cardiometabolic diseases

14:25 - 14:30
(CEST)

Checking the contents page: welcome back

Alice Cheng, Mikael Rydén
14:30 - 14:45
(CEST)

Chapter 14: Advancements in nutrient-stimulated hormone therapies: the evolution of amylin

Matthias Blüher
14:45 - 15:00
(CEST)

Chapter 15: Advancements to clinical excellence in obesity through the potential of complementary biologies

W. Timothy Garvey
15:00 - 15:15
(CEST)

Chapter 16: Advancements across the metabolic disease continuum - expanding the evidence

Melanie Davies
15:15 - 15:30
(CEST)

Chapter 17: Advancements in the treatment toolbox - integrating amycretin

Ania Jastreboff
15:30 - 15:50
(CEST)

Chapter 18: Summarising the advancements and looking to a future of clinical excellence

Alice Cheng
16:05 - 17:00
(CEST)

Part 5: Innovating our heritage - once-weekly basal insulin therapy

16:05 - 16:10
(CEST)

Checking the contents page: welcome back

Alice Cheng, Mikael Rydén
16:10 - 16:30
(CEST)

Chapter 19: Innovation in basal insulins - individualised treatment in focus

Athena Philis-Tsimikas, Harald Sourij
16:30 - 16:45
(CEST)

Chapter 20: Innovation in combination insulin therapy - benefits beyond glycaemic control

Linong Ji​​
16:45 - 16:55
(CEST)

Chapter 21: Summarising the innovation for people in need of insulin

Alice Cheng, Mikael Rydén, Athena Philis-Tsimikas, Harald Sourij, Linong Ji​​
16:55 - 17:00
(CEST)

The Epilogue: summary and close

Alice Cheng, Mikael Rydén